Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Stock
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
18.2M
-
Shares change
-
-4.03M
-
Total reported value, excl. options
-
$64M
-
Value change
-
-$17.3M
-
Put/Call ratio
-
0.13
-
Number of buys
-
33
-
Number of sells
-
-54
-
Price
-
$3.51
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q2 2021
102 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q2 2021.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.2M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (5.77M shares), VANGUARD GROUP INC (2.44M shares), FRANKLIN RESOURCES INC (1.9M shares), DSC Advisors, L.P. (1.1M shares), BlackRock Inc. (1.04M shares), 683 Capital Management, LLC (734K shares), MILLENNIUM MANAGEMENT LLC (679K shares), STATE STREET CORP (535K shares), GEODE CAPITAL MANAGEMENT, LLC (467K shares), and Healthcare Value Capital, LLC (450K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.